LUCY HOGAN: Open Payments
NPI 1710549274 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 19 payments from 10 companies in 2025. Trend: 2023 $994 · 2024 $1,287 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $197 |
| Novo Nordisk Inc | 7 | $157 |
| Neurocrine BioSciences, Inc. | 1 | $136 |
| Lilly USA, LLC | 3 | $132 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $95 |
| ACADIA Pharmaceuticals Inc | 1 | $85 |
Products named: AIRSUPRA, INGREZZA, INVEGA SUSTENNA, ZENPEP, Wegovy, Auvelity, REXULTI, JARDIANCE.
Industry payments across OH — which companies pay providers there.
